nach oben

NeuroMolecular Medicine

Erschienen in:

01.12.2010 | Review Paper

Sphingolipids in Neurodegeneration

verfasst von: Norman J. Haughey

Erschienen in: NeuroMolecular Medicine | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Although the brain contains a high content of sphingolipids, we know relatively little about the roles that sphingolipids play in regulating neural functions. Once regarded only for their structural roles in maintaining the integrity of cellular and sub-cellular compartments, it is now apparent that many sphingolipid species are biologically active and play important roles in regulating signaling events. Recent technological and scientific advances are rapidly increasing our knowledge of the roles that sphingolipids play in regulating normal neural activity. Likewise, we are beginning to understand how perturbations in sphingolipid metabolism contribute to the pathogenesis of a variety of neurodegenerative conditions. In this special issue of NeuroMolecular Medicine, we present a series of review articles that summarize new and emerging technologies for the analysis of sphingolipids, sphingolipid metabolic pathways, and how dysfunctions in sphingolipid metabolism contribute to neurodegeneration in lysosomal storage disorders, Alzheimer’s disease and Multiple Sclerosis.

Abulrob, A., Tauskela, J. S., Mealing, G., Brunette, E., Faid, K., & Stanimirovic, D. (2005). Protection by cholesterol-extracting cyclodextrins: A role for N-methyl-D-aspartate receptor redistribution. Journal of Neurochemistry, 92, 1477–1486.CrossRefPubMed

Assaife-Lopes, N., Sousa, V. C., Pereira, D. B., Ribeiro, J. A., Chao, M. V., & Sebastiao, A. M. (2010). Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: Implications for neuromodulation. Journal of Neuroscience, 30, 8468–8480.CrossRefPubMed

Bajjalieh, S. M., Martin, T. F., & Floor, E. (1989). Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. Journal of Biological Chemistry, 264, 14354–14360.PubMed

Bandaru, V. V., McArthur, J. C., Sacktor, N., Cutler, R. G., Knapp, E. L., Mattson, M. P., et al. (2007). Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology, 68, 1481–1487.CrossRefPubMed

Bandaru, V. V., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., et al. (2009). ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer’s but not normal brain. Neurobiology of Aging, 30, 591–599.CrossRefPubMed

Besshoh, S., Bawa, D., Teves, L., Wallace, M. C., & Gurd, J. W. (2005). Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. Journal of Neurochemistry, 93, 186–194.CrossRefPubMed

Blochl, A., & Thoenen, H. (1996). Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons. Molecular and Cellular Neurosciences, 7, 173–190.CrossRefPubMed

Blood, P. D., & Voth, G. A. (2006). Direct observation of Bin/amphiphysin/Rvs (BAR) domain-induced membrane curvature by means of molecular dynamics simulations. Proceedings of the National Academy of Sciences of the United States of America, 103, 15068–15072.CrossRefPubMed

Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber, M., et al. (1999). Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. Journal of Neuroscience, 19, 8199–8206.PubMed

Bryant, M. R., Marta, C. B., Kim, F. S., & Bansal, R. (2009). Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia, 57, 935–946.CrossRefPubMed

Coogan, A. N., O’Neill, L. A., & O’Connor, J. J. (1999). The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience, 93, 57–69.CrossRefPubMed

Darios, F., Wasser, C., Shakirzyanova, A., et al. (2009). Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron, 62, 683–694.CrossRefPubMed

Davis, C. N., Tabarean, I., Gaidarova, S., Behrens, M. M., & Bartfai, T. (2006). IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. Journal of Neurochemistry, 98, 1379–1389.CrossRefPubMed

Day, C. A., & Kenworthy, A. K. (2009). Tracking microdomain dynamics in cell membranes. Biochimica et Biophysica Acta, 1788, 245–253.CrossRefPubMed

Delint-Ramirez, I., Fernandez, E., Bayes, A., Kicsi, E., Komiyama, N. H., & Grant, S. G. (2010). In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93. Journal of Neuroscience, 30, 8162–8170.CrossRefPubMed

Fasano, C., Miolan, J. P., & Niel, J. P. (2003). Modulation by C2 ceramide of the nicotinic transmission within the coeliac ganglion in the rabbit. Neuroscience, 116, 753–759.CrossRefPubMed

Frank, C., Giammarioli, A. M., Pepponi, R., Fiorentini, C., & Rufini, S. (2004). Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Letters, 566, 25–29.CrossRefPubMed

Fullekrug, J., & Simons, K. (2004). Lipid rafts and apical membrane traffic. Annals of the New York Academy of Sciences, 1014, 164–169.CrossRefPubMed

Furukawa, K., & Mattson, M. P. (1998). The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. Journal of Neurochemistry, 70, 1876–1886.CrossRefPubMed

Furuya, S., Mitoma, J., Makino, A., & Hirabayashi, Y. (1998). Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. Journal of Neurochemistry, 71, 366–377.CrossRefPubMed

Harlan, J. E., Hajduk, P. J., Yoon, H. S., & Fesik, S. W. (1994). Pleckstrin homology domains bind to phosphatidylinositol-4, 5-bisphosphate. Nature, 371, 168–170.CrossRefPubMed

Haughey, N. J., Cutler, R. G., Tamara, A., McArthur, J. C., Vargas, D. L., Pardo, C. A., et al. (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Annals of Neurology, 55, 257–267.CrossRefPubMed

Hering, H., Lin, C. C., & Sheng, M. (2003). Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. Journal of Neuroscience, 23, 3262–3271.PubMed

Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., et al. (1996). Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. Journal of Cell Biology, 135, 37–51.CrossRefPubMed

Inokuchi, J., Mizutani, A., Jimbo, M., et al. (1998). A synthetic ceramide analog (L-PDMP) up-regulates neuronal function. Annals of the New York Academy of Sciences, 845, 219–224.CrossRefPubMed

Ito, A., & Horigome, K. (1995). Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. Journal of Neurochemistry, 65, 463–466.CrossRefPubMed

Jeon, H. J., Lee, D. H., Kang, M. S., Lee, M. O., Jung, K. M., Jung, S. Y., et al. (2005). Dopamine release in PC12 cells is mediated by Ca(2+)-dependent production of ceramide via sphingomyelin pathway. Journal of Neurochemistry, 95, 811–820.CrossRefPubMed

Kajimoto, T., Okada, T., Yu, H., Goparaju, S. K., Jahangeer, S., & Nakamura, S. (2007). Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Molecular and Cellular Biology, 27, 3429–3440.CrossRefPubMed

Kutateladze, T. G., Ogburn, K. D., Watson, W. T., de Beer, T., Emr, S. D., Burd, C. G., et al. (1999). Phosphatidylinositol 3-phosphate recognition by the FYVE domain. Molecular Cell, 3, 805–811.CrossRefPubMed

Levental, I., Grzybek, M., & Simons, K. (2010). Greasing their way: Lipid modifications determine protein association with membrane rafts. Biochemistry, 49, 6305–6316.CrossRefPubMed

Liu, Y., Fisher, D. A., & Storm, D. R. (1993). Analysis of the palmitoylation and membrane targeting domain of neuromodulin (GAP-43) by site-specific mutagenesis. Biochemistry, 32, 10714–10719.CrossRefPubMed

Low, M. G. (1989). Glycosyl-phosphatidylinositol: A versatile anchor for cell surface proteins. The FASEB Journal, 3, 1600–1608.PubMed

Magee, A. I., Gutierrez, L., Marshall, C. J., & Hancock, J. F. (1989). Targeting of oncoproteins to membranes by fatty acylation. Journal of Cell Science. Supplement, 11, 149–160.PubMed

Medkova, M., & Cho, W. (1999). Interplay of C1 and C2 domains of protein kinase C-alpha in its membrane binding and activation. Journal of Biological Chemistry, 274, 19852–19861.CrossRefPubMed

Numakawa, T., Nakayama, H., Suzuki, S., et al. (2003). Nerve growth factor-induced glutamate release is via p75 receptor, ceramide, and Ca(2+) from ryanodine receptor in developing cerebellar neurons. Journal of Biological Chemistry, 278, 41259–41269.CrossRefPubMed

Owen, D. M., Williamson, D., Rentero, C., & Gaus, K. (2009). Quantitative microscopy: Protein dynamics and membrane organisation. Traffic, 10, 962–971.CrossRefPubMed

Ping, S. E., & Barrett, G. L. (1998). Ceramide can induce cell death in sensory neurons, whereas ceramide analogues and sphingosine promote survival. Journal of Neuroscience Research, 54, 206–213.CrossRefPubMed

Rohrbough, J., Rushton, E., Palanker, L., Woodruff, E., Matthies, H. J., Acharya, U., et al. (2004). Ceramidase regulates synaptic vesicle exocytosis and trafficking. Journal of Neuroscience, 24, 7789–7803.CrossRefPubMed

Santagata, S., Boggon, T. J., Baird, C. L., Gomez, C. A., Zhao, J., Shan, W. S., et al. (2001). G-protein signaling through tubby proteins. Science, 292, 2041–2050.CrossRefPubMed

Stahelin, R. V. (2009). Lipid binding domains: More than simple lipid effectors. Journal of Lipid Research, 50 Suppl, S299–S304.PubMed

Stahelin, R. V., Long, F., Peter, B. J., Murray, D., De Camilli, P., McMahon, H. T., et al. (2003). Contrasting membrane interaction mechanisms of AP180 N-terminal homology (ANTH) and epsin N-terminal homology (ENTH) domains. Journal of Biological Chemistry, 278, 28993–28999.CrossRefPubMed

Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M., & Hancock, J. F. (1994). Activation of Raf as a result of recruitment to the plasma membrane. Science, 264, 1463–1467.CrossRefPubMed

Swartz, K. J. (2008). Sensing voltage across lipid membranes. Nature, 456, 891–897.CrossRefPubMed

Tabarean, I. V., Korn, H., & Bartfai, T. (2006). Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience, 141, 1685–1695.CrossRefPubMed

Thelen, M., Rosen, A., Nairn, A. C., & Aderem, A. (1991). Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature, 351, 320–322.CrossRefPubMed

Wheeler, D., Knapp, E., Bandaru, V. V., Wang, Y., Knorr, D., Poirier, C., et al. (2009). Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. Journal of Neurochemistry, 109, 1237–1249.CrossRefPubMed

Yang, S. N. (2000). Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: An essential role of postsynaptic protein phosphatases. Neuroscience, 96, 253–258.CrossRefPubMed

Yin, X., Zafrullah, M., Lee, H., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2009). A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cellular Physiology and Biochemistry, 24, 219–230.CrossRefPubMed

Titel: Sphingolipids in Neurodegeneration
verfasst von: Norman J. Haughey
Publikationsdatum: 01.12.2010
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 4/2010
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-010-8135-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

An Introduction to Sphingolipid Metabolism and Analysis by New Technologies

Sphingolipids in Multiple Sclerosis

The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases

Pathology and Current Treatment of Neurodegenerative Sphingolipidoses

Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?